US Patent Issued to Bristol-Myers Squibb on Feb. 18 for "Methods of treating a tumor using an anti-PD-1 antibody" (Pennsylvania Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,576, issued on Feb. 18, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Methods of treating a tumor using an anti-PD-1 antibody" was invented by Robin Edwards (Newtown, Pa.), William J. Geese (Pipersville, Pa.) and Danielle M. Greenawalt (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from a non-small cell lung can...